Meningitis outbreak prompts discussion of pharmacy conditions
By Jonathan Serrie
Published October 23, 2012
FoxNews.com
Four weeks after the recall of tainted steroids amid a deadly fungal meningitis outbreak, it remains unclear how widespread the problem is.
MIAMI – JULY 14: Pills of the diabetes drug, Avandia are seen on July 14, 2010 in Miami, Florida. Today, the U.S. Food and Drug Administration panel voted to recommend that GlaxoSmithKline PLC’s (GSK) diabetes drug, Avandia, remain on the market despite concerns that the product could raise the risk of heart attacks. (Image credit: Getty Images via @daylife)
The Food and Drug Administration
removed a list of clinics Monday that received products from the New England
Compounding Center, just hours after posting it on its website.
“FDA has found some technical problems
with the list and the data are incorrect,” a note on the FDA’s website
explained. “FDA is working to correct the list and will re-post when we
are sure it is accurate.”
Related articles
About James SmithJames is a father of four and grandfather to four cute little bugs. He and his wife Beautiful Gorgeous, of almost 30 years, have been prepping since 2003.
View all posts by James Smith →
Google+
You must be logged in to post a comment Login